Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00242437 · ClinicalTrials.gov registry record · Phase 4
Hemostatic Matrix in Endoscopic Sinus Surgery
A Phase 4 study, sponsored by Ethicon.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT00242437: Completed Phase 4 study, sponsored by Ethicon.
NCT00242437 is a Phase 4 study that has completed, run by Ethicon. The registered enrollment target is 30 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00242437, a Phase 4 study, has completed, sponsored by Ethicon.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
Evaluating clinical performance of Hemostatic Matrix with bovine thrombin in achieving hemostasis in patients undergoing endoscopic sinus surgery.
Interventions
- DEVICE Hemostatic matrix
- DEVICE bovine thrombin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2005-10 |
| Est. Completion | 2006-02 |
| Phase | Phase 4 |
What the finished NCT00242437 record still lists
NCT00242437 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Hemostatic matrix is the first listed.
NCT00242437 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00242437 about?
NCT00242437 is a clinical study titled "Hemostatic Matrix in Endoscopic Sinus Surgery". Evaluating clinical performance of Hemostatic Matrix with bovine thrombin in achieving hemostasis in patients undergoing endoscopic sinus surgery.
What is the current status of trial NCT00242437?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2005-10. Estimated completion is 2006-02.
What interventions are being tested in trial NCT00242437?
The interventions under investigation include: Hemostatic matrix (DEVICE), bovine thrombin (DEVICE).
Who is sponsoring clinical trial NCT00242437?
This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00242437's enrollment target sits among peer trials
30 1552nd of 2000 higher than 367 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia